Arcus Biosciences, Inc. (RCUS)
21.95
-0.29
(-1.30%)
USD |
NYSE |
Apr 07, 13:07
Arcus Biosciences SG&A Expense (TTM) : 110.00M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Gilead Sciences, Inc. | 8.398B |
| Merck & Co., Inc. | 10.73B |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| Alnylam Pharmaceuticals, Inc. | 1.211B |
| Regeneron Pharmaceuticals, Inc. | 2.70B |